Some Physicians Warn Against Warp Speed COVID Vaccinations for Children
On Oct. 29, 2021 the U.S Food and Drug Administration (FDA) approved the use of Pfizer/BioNTech COVID-19 vaccine by five- to 11-year-old children under federal Emergency Use Authorization (EUA) guidelines. As California became the first state to announce that COVID vaccine will be required for children to attend school, districts in several other states plan […]
The Growing Specter of Compulsory Vaccination
The pace of discrimination against people who have opted not to get a COVID-19 vaccine is increasing around the world as the ominous specter of compulsory vaccination grows. On Nov. 19, 2021, the Chancellor of Austria, Alexander Schallenberg, announced at a press conference that, beginning on Feb. 1, 2022, COVID vaccinations will be compulsory for […]
Grassroots Resistance in Europe and Australia to Vaccine Mandates and Lockdowns Escalate as COVID Vaccines Fail
Despite nearly two years of persistent public protests in major cities in Europe and Australia, the governments currently in power have declined to respond to the deep concerns of significant numbers of people living in western democracies, who are opposed to the suspension of civil liberties associated with COVID-19 vaccine mandates and lockdowns.
Renewable Travel Pass May Signal Annual Booster Shots for European Union
As part of an effort to reopen their borders and encourage travelers from outside of Europe, the 27 member states of the European Union (E.U.) began issuing an “E.U. Digital COVID Certificate” (EUDCC) on July 1, 2021 to people who have receive COVID vaccinations to allow freedom of movement within the region. The travel scheme, […]
Merck and Pfizer Seek Approval for COVID-19 Antiviral Drugs
Merck and Pfizer have submitted Emergency Use Authorization (EUA) applications to the U.S. Food and Drug Administration (FDA) to authorize distribution of what would be the first antiviral drug specifically designed to treat COVID-19 disease.1 Merck/Ridgeback Biotherapeutics are seeking EUA approval for Molnupiravir (MK-4482/EIDD-2801), an investigational oral antiviral drug originally developed to treat influenza.2 Pfizer […]
Efficacy of Pfizer’s COVID Biologic Estimated at 33 Percent
A recent study soon to be published in the Journal of Medical Biochemistry found that Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 significantly loses its efficacy within six months of the second shot. Researchers from the University of Verona in Italy and Cincinnati Children’s Hospital Medical Center in Ohio looked at 787 health […]